Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies
Degron
DOI:
10.1371/journal.pgen.1006683
Publication Date:
2017-03-27T19:31:01Z
AUTHORS (46)
ABSTRACT
Schinzel-Giedion syndrome (SGS) is a rare developmental disorder characterized by multiple malformations, severe neurological alterations and increased risk of malignancy. SGS caused de novo germline mutations clustering to 12bp hotspot in exon 4 SETBP1. Mutations this disrupt degron, signal for the regulation protein degradation, lead accumulation SETBP1 protein. Overlapping have been observed recurrently as somatic events leukemia. We collected clinical information 47 patients (including 26 novel cases) with four individuals milder phenotype adjacent hotspot. Different within around varying effects on stability levels vitro silico modeling. Substitutions residue I871 result weak increase affecting are significantly more frequent than On other hand, substitutions D868 largest levels. Individuals enhanced cell proliferation higher incidence cancer compared mutations. Our findings substantiate that, despite their overlap, driving malignancy disruptive degron causing SGS. Additionally, suggests that functional threshold development driven disruption alteration prenatal Drawing previous studies leukemia, our results reveal genotype-phenotype correlation spanning molecular, cellular phenotype.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (69)
CITATIONS (51)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....